Evidence map›Paper›PMID 33215740›Full record

ArticleThe EMBO journal2020

Site-specific ubiquitination of the E3 ligase HOIP regulates apoptosis and immune signaling.

Lilian M Fennell, Carlos Gomez Diaz, Luiza Deszcz, Anoop Kavirayani, David Hoffmann, Kota Yanagitani, Alexander Schleiffer, Karl Mechtler, Astrid Hagelkruys, Josef Penninger and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer.Journal of experimental & clinical cancer research : CR · 2024
    Review
  5. Article
  6. Site-specific ubiquitination: Deconstructing the degradation tag.Current opinion in structural biology · 2022
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Lilian M FennellInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Vienna, Austria.
Carlos Gomez DiazInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Vienna, Austria.ORCID 0000-0002-6416-806X
Luiza DeszczInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Vienna, Austria.
Anoop KavirayaniVienna Biocenter Core Facilities (VBCF), Vienna Biocenter (VBC), Vienna, Austria.
David HoffmannInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Vienna, Austria.
Kota YanagitaniMedical Institute of Bioregulation (MIB), Kyushu University, Fukuoka, Japan.
Alexander SchleifferInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Vienna, Austria.ORCID 0000-0001-6251-2747
Karl MechtlerInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Vienna, Austria.ORCID 0000-0002-3392-9946
Astrid HagelkruysInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Vienna, Austria.
Josef PenningerInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Vienna, Austria.ORCID 0000-0002-8194-3777
Fumiyo IkedaInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Vienna, Austria.ORCID 0000-0003-0407-2768
Institute of Molecular Biotechnology · ATKyushu University · JPVienna Biocenter · AT

Funding

Austrian Science Fund ERA-CAPS 3686 projectAustrian Science Fund (FWF) P 2550 8ERA-CAPS I 3686Canada 150 ChairFP7 Ideas: European Research Council (FP7 Ideas) 614711MEXT | Japan Society for the Promotion of Science (JSPS) 18K19959The Horizon 2020 EPIC-XS 823839the von Zastrow Foundation
6 · The paper itself

Abstract

HOIP, the catalytic component of the linear ubiquitin chain assembly complex (LUBAC), is a critical regulator of inflammation. However, how HOIP itself is regulated to control inflammatory responses is unclear. Here, we discover that site-specific ubiquitination of K784 within human HOIP promotes tumor necrosis factor (TNF)-induced inflammatory signaling. A HOIP K784R mutant is catalytically active but shows reduced induction of an NF-κB reporter relative to wild-type HOIP. HOIP K784 is evolutionarily conserved, equivalent to HOIP K778 in mice. We generated Hoip

Indexed as

AnimalsApoptosisFemaleGene Knock-In TechniquesHEK293 CellsHumansMaleMiceNF-kappa BReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IISignal TransductionTranscriptomeUbiquitinUbiquitinationUbiquitin-Protein LigasesNF-kappa BReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IIRnf31 protein, mouseTnfrsf1a protein, mouseUbiquitinUbiquitin-Protein LigasesapoptosisHOIP E3 ligaselinear ubiquitinationskin inflammationTNF

Identifiers

PMID33215740
PMCPMC7737615
OpenAlexW3102210030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.